Skip to main content

Table 1 Baseline characteristics

From: Estimating health related quality of life effects in vitiligo. Mapping EQ-5D-5 L utilities from vitiligo specific scales: VNS, VitiQoL and re-pigmentation measures using data from the HI-Light trial

  

TCS

(N = 173)

NB-UVB

(N = 169)

TCS + NB-UVB

(N = 175)

Total

(N = 517)

Gender

     

 Female

n (%)

98 (57%)

81 (48%)

70 (40%)

249 (48%)

 Male

n (%)

75 (43%)

88 (52%)

105 (60%)

268 (52%)

Ethnicity

 White

n (%)

112 (65%)

114 (67%)

104 (59%)

330 (64%)

 Indian

n (%)

13 (8%)

13 (8%)

10 (6%)

36 (7%)

 Pakistani

n (%)

12 (7%)

15 (9%)

27 (15%)

54 (10%)

 Bangladeshi

n (%)

4 (2%)

4 (2%)

4 (2%)

12 (2%)

 Black

n (%)

5 (3%)

3 (2%)

7 (4%)

15 (3%)

 Chinese

n (%)

2 (1%)

1 (1%)

1 (1%)

4 (1%)

 Other Asian (not Chinese)

n (%)

5 (3%)

6 (4%)

6 (3%)

17 (3%)

 Mixed race

n (%)

9 (5%)

6 (4%)

6 (3%)

21 (4%)

 Other

n (%)

10 (6%)

7 (4%)

9 (5%)

26 (5%)

 Missing

n (%)

1 (1%)

0

1 (1%)

2 (< 1%)

Age at Randomization (years)

     

N

173

169

175

517

Mean (SD)

38.6 (20.0)

36.9 (18.9)

37.0 (19.1)

37.5 (19.3)

Age of adults at Randomization (years)

     

N

133

130

135

398

Mean (SD)

46.7 (15.2)

44.7 (14.0)

44.8 (14.2)

45.4 (14.47)

Age of children at Randomization (years)

     

N

40

39

40

119

Mean (SD)

11.7 (3.7)

10.8 (3.5)

10.6 (3.3)

11.03 (3.5)

  1. SD Standard deviation, TCS Topical Corticoid Steroids. NB-UVB Narrowband Ultraviolet B (a form of phototherapy)